Cancer News

Study: HPV cancer survivors at risk for second HPV cancerSep 7, 2018
A retrospective study found that survivors of HPV-associated cancers have a high incidence of developing second HPV-related cancers.
Research leads to rare ER+ breast cancer mutations insightSep 4, 2018
Researchers conducted the largest analysis to date to establish associations between rare somatic mutations and prognosis in estrogen receptor positive (ER+) breast cancer
New histiocytotic disorder insights may improve therapiesAug 30, 2018
In a review published in New England Journal of Medicine, physician-scientists review the history of Langerhans-cell histiocytosis (LCH) and the recent developments that will help propel the treatment for patients into the realm of personalized medicine.
Non-alcoholic fatty liver disease a risk factor for liver cancerAug 27, 2018
To establish a better understanding of the link between the risk for liver cancer and non-alcoholic fatty liver disease (NAFLD), researchers conducted a large, retrospective study of patients with and without NAFLD.
Baylor awarded CPRIT Grants for research, recruitmentAug 27, 2018
Baylor College of Medicine has been awarded more than $31 million by the Cancer Prevention & Research Institute of Texas (CPRIT) to support new research, core facilities and recruitment of new faculty to support the fight against cancer.
Companies merge to implement Baylor College of Medicine-developed therapies for cancerAug 8, 2018
Researchers have developed a novel therapy for cancer patients that harnesses the patient’s own immune system to fight cancer in a natural way.
Altered gene regulation is more widespread in cancer than expected Jul 10, 2018
A team of researchers conducted a large-scale study that provides new insights into the mechanisms that can lead to cancer.
How good bacteria keeps your gut healthyJul 3, 2018
New research reveals a cellular mechanism by which good bacteria can help the gut stay healthy.
First-in-human clinical trial aims to treat neuroblastomaJun 15, 2018
In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
Baylor endorses goal to eliminate HPV-related cancersJun 7, 2018
Baylor and each of the National Cancer Institute-designated cancer centers in issuing a joint statement in support of initiatives to eliminate cancers caused by the human papillomavirus (HPV).